Get the Stockscreener App
13.50
4.19%
-0.59
Pre-market:
13.70
0.20
+1.48%
Rxsight Inc stock is traded at $13.50, with a volume of 731.33K.
It is down -4.19% in the last 24 hours and down -4.86% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$14.09
Open:
$13.96
24h Volume:
731.33K
Relative Volume:
0.74
Market Cap:
$637.59M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-16.46
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-13.96%
1M Performance:
-4.86%
6M Performance:
-64.51%
1Y Performance:
-75.94%
1-Day Range:
$13.41
$14.09
1-Week Range:
$13.41
$15.81
52-Week Range:
$12.53
$60.81
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
13.50 | 637.59M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Market Insight: RxSight Inc (RXST)’s Notable Drop, Closing at 13.50 - DWinneX
The Price Is Right For RxSight, Inc. (NASDAQ:RXST) - simplywall.st
When (RXST) Moves Investors should Listen - news.stocktradersdaily.com
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Hold” by Analysts - Defense World
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued - MSN
RxSight Stock: Valuation Blowout Creates Opportunity (NASDAQ:RXST) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,140 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight Inc (RXST) Stock Price Down 3.04% on Jun 4 - GuruFocus
Where are the Opportunities in (RXST) - news.stocktradersdaily.com
RxSight Inc (RXST) Shares Down 7.27% on May 30 - GuruFocus
Midday Stock Roundup: Tilly’s Up 14% Ahead of Q1 Results - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Nuveen Asset Management LLC - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight at Stifel Forum: Navigating Market Challenges By Investing.com - Investing.com Canada
RxSight, Inc. (NASDAQ:RXST) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
RxSight (NASDAQ:RXST) Stock Price Down 4.7% – Here’s Why - Defense World
(RXST) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Do Options Traders Know Something About RxSight Stock We Don't? - TradingView
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire
RxSight (NASDAQ:RXST) Upgraded to Overweight at Wells Fargo & Company - Defense World
RxSight Inc (RXST) Stock Price Up 13.14% on May 19 - GuruFocus
Sector Update: Health Care - marketscreener.com
RxSight Shares Rise After Upgrade From Wells Fargo - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 By Investing.com - Investing.com Canada
RXST Sees Rating Upgrade and Price Target Increase by Wells Farg - GuruFocus
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings) - Benzinga
Wells Fargo Upgrades RxSight (RXST) - Nasdaq
Wells Fargo Upgrades RxSight to Overweight From Equalweight, Lifts Price Target to $25 From $17 - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 - Investing.com Australia
Wells Fargo Upgrades RxSight (RXST) with Increased Price Target | RXST Stock News - GuruFocus
RxSight (RXST) Receives Upgrade from Wells Fargo with Increased Price Target | RXST Stock News - GuruFocus
Wells Fargo upgrades RxSight on ‘strong first-mover advantage’ - TipRanks
RxSight Inc (RXST) Stock Price Up 5.15% on May 16 - GuruFocus
Northern Trust Corp Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : RxSight, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Price T Rowe Associates Inc. MD Sells 23,863 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating - marketscreener.com
RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Dimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Insiders Who Purchased US$1.42m Of RxSight Stock May Not Have Expected 12% Tumble - simplywall.st
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
RxSight: Favorable Risk/Reward Scenario with Strong Growth Prospects and Attractive Valuation - TipRanks
RxSight (NASDAQ:RXST) Sets New 12-Month Low After Earnings Miss - Defense World
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):